Search

Illumina Inc

Cerrado

SectorSanidad

206.44 2.63

Resumen

Variación precio

24h

Actual

Mínimo

205.68

Máximo

208.19

Métricas clave

By Trading Economics

Ingresos

-268M

-134M

Ventas

68M

1.2B

P/B

Media del Sector

40.637

56.597

BPA

1.31

Margen de beneficios

-11.562

Empleados

8,600

EBITDA

80M

330M

Dividendos

By Acuity

Próximas Ganancias

29 oct 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

4.3B

33B

Apertura anterior

203.81

Cierre anterior

206.44

Noticias sobre sentimiento de mercado

By Acuity

45%

55%

115 / 339 Clasificación en Healthcare

Illumina Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

11 sept 2026, 20:01 UTC

Illumina Inc's shares are higher Friday, continuing an upward trend since Thursday's close. No specific news was identified to explain the movement.

9 sept 2026, 20:07 UTC

Illumina Inc shares are lower today, continuing a decline since Tuesday's close. The stock remains below its 20-day moving average.

8 sept 2026, 23:51 UTC

Illumina Inc shares are higher in after-market trading, showing notable activity and positioning above the 20-day moving average amid a lack of specific news.

5 sept 2026, 00:05 UTC

News

Illumina Inc will join the S&P 500 on September 21, 2026. Shares are advancing in after-market hours following the announcement.

4 sept 2026, 23:02 UTC

News

Illumina Inc will join the S&P 500 index effective September 21, 2026, following an announcement by Dow Jones Indices. Shares are trading higher after the news.

3 sept 2026, 20:07 UTC

News

Illumina shares are higher as analysts raise price targets, with Argus at $235 and Baird at $225, reflecting increased confidence in the company.

2 sept 2026, 22:56 UTC

Illumina Inc's shares are higher in after-market hours following Wednesday's close, maintaining a position above its 20-day moving average. No specific news was identified.

1 sept 2026, 20:09 UTC

Illumina Inc's shares are lower today, continuing a downward trend observed since Monday. The stock has reached a session low, marking a third consecutive decline.

31 ago 2026, 23:36 UTC

Illumina Inc. shares declined in after-market trading, following hawkish comments from Federal Reserve Chair Kevin Warsh that affected market sentiment.

28 ago 2026, 23:16 UTC

Illumina Inc's shares are higher in after-market trading, reflecting positive momentum since Friday's close and routine trading activity within a narrow range.

27 ago 2026, 20:07 UTC

Illumina Inc shares are higher during Thursday's session, supported by a decline in initial jobless claims, though no specific company news was identified.

26 ago 2026, 20:07 UTC

News

Illumina Inc shares are lower today amid a broader downturn in the Life Sciences Tools & Services sub-sector. Analysts estimate fair value at $172.53.

25 ago 2026, 20:07 UTC

News

Illumina Inc shares are advancing as investor sentiment improves ahead of a meeting with Piper Sandler scheduled for August 27.

24 ago 2026, 20:02 UTC

Social Media
News

Illumina Inc reported second-quarter earnings of $1.31 per share, with revenue of $1.16 billion, surpassing estimates. Shares are advancing during Monday's session.

21 ago 2026, 19:16 UTC

Illumina Inc shares are higher today, recovering from earlier losses and remaining above the 20-day moving average for the third consecutive session.

20 ago 2026, 20:02 UTC

Illumina Inc's shares are higher today, building on gains since Wednesday. The stock is trading near the upper end of its one-month range.

19 ago 2026, 20:02 UTC

Correlated Moves

Illumina Inc. shares are higher, buoyed by strong momentum in the genomics sector and a notable rise in the ARK Genomic Revolution ETF.

17 ago 2026, 19:54 UTC

News

Illumina Inc's stock is higher, supported by a Yahoo Finance article discussing its price target of $198.89 and concerns over organic sales performance.

13 ago 2026, 20:06 UTC

Illumina Inc's shares are lower amid declines in the Life Sciences Tools & Services sector, with no specific company news identified for the movement.

12 ago 2026, 22:02 UTC

Illumina Inc shares are lower in after-market hours with no specific news identified. Broader market conditions reflect mixed performance amid inflation data.

11 ago 2026, 19:16 UTC

Illumina Inc. shares are trading higher, recovering from an early dip during Tuesday's session. No specific news or developments were identified.

10 ago 2026, 23:16 UTC

Correlated Moves

Illumina Inc shares fell in after-hours trading, tracking a broader decline in the Russell 2000 Index amid rising U.S. Treasury yields and inflation concerns.

7 ago 2026, 19:46 UTC

News

Illumina Inc shares are lower after Director Keith A. Meister sold 283,269 shares, raising investor concerns about the company's valuation.

6 ago 2026, 23:06 UTC

Illumina Inc shares are lower in after-market trading following Thursday's close, despite an initial uptick. No specific news was identified to explain the decline.

5 ago 2026, 19:52 UTC

Correlated Moves

Illumina shares are lower following disappointing first-quarter results and broader market declines. ADP's report on weak job growth has added to cautious sentiment.

4 ago 2026, 19:31 UTC

Correlated Moves

Illumina Inc's shares are higher today, reflecting a broader market trend as the Russell 2000 Index also advances. The stock is near its one-month range high.

3 ago 2026, 20:03 UTC

News

Illumina shares are lower today as Citigroup maintains a Sell rating and raises its price target to $113 amid mixed analyst sentiment.

31 jul 2026, 23:06 UTC

News

Illumina Inc reported strong Q2 results and raised full-year guidance, yet shares declined in after-market trading from Friday's close of $202.95.

30 jul 2026, 23:41 UTC

News
Social Media

Illumina Inc shares declined in after-market trading despite strong second-quarter results and raised full-year EPS guidance, reflecting concerns over falling net income.

29 jul 2026, 23:26 UTC

Illumina Inc. shares declined after-market amid overall market volatility following the Federal Reserve's decision to maintain interest rates amid rising inflation concerns.

Comparación entre iguales

Cambio de precio

Illumina Inc previsión

Consenso

By TipRanks

Compra Moderada

17 ratings

9

Comprar

5

Mantener

3

Vender

Sentimiento

By Acuity

115 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat